Improved Legionella selective media by the addition of fluconazole: results of in vitro testing and clinical evaluation.
University of Pittsburgh, PA, USA.
A
A
Lin
J E
JE
Stout
J D
JD
Rihs
R M
RM
Vickers
V L
VL
Yu
D000841:Anisomycin / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology*; D001431:Bacteriological Techniques; D002176:Candida albicans / Q000187:drug effects / Q000254:growth & development; D017714:Community-Acquired Infections / Q000382:microbiology; D003470:Culture Media; D005069:Evaluation Studies as Topic; D015725:Fluconazole / Q000494:pharmacology*; D006801:Humans; D007875:Legionella / Q000187:drug effects* / Q000254:growth & development / Q000302:isolation & purification*; D016952:Legionella pneumophila / Q000187:drug effects / Q000254:growth & development / Q000302:isolation & purification; D007877:Legionnaires' Disease / Q000382:microbiology; D018410:Pneumonia, Bacterial / Q000382:microbiology; D011446:Prospective Studies; D013183:Sputum / Q000382:microbiology; D015003:Yeasts / Q000187:drug effects* / Q000254:growth & development
D000935:Antifungal Agents; D003470:Culture Media; D000841:Anisomycin; D015725:Fluconazole